Founded in 2019, Yapan Bio operates in Health Tech offering research-based clinical nutrition solutions. The company focuses on onco-nutrition and aims to provide comprehensive solutions for disease m...
Funding stage:
Corporate Round
Last funding:
21/12/2021
Total funding:
$13.57 Mn+
Revenue:
Investors
Employee count:
55
Last 90d
55
Last 90d
Web traffic:
578
578
Last 30d
Last 30d
Glassdoor Rating:
Yapan Bio: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders3
Latest Filing Date30 March 2022- Funding Events7
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Yapan Bio
As of 31 March 2022, Yapan Bio's equity is held by 3 shareholders, with the top three being Atin Tomar, Nirav Desai, and Piramal Group.
Atin Tomar holds the largest stake in Yapan Bio at 36.1% as of 31 March 2022.
As of 31 March 2022, founders collectively hold 72.2% equity in Yapan Bio.
As of 31 March 2022, investors collectively hold 27.8% equity in Yapan Bio.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links